CLGN
CollPlantยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CLGN Profile
Collplant Biotechnologies Ltd.
A regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs, and medical aesthetics
Biological Technology
11/09/1981
01/31/2018
NASDAQ Stock Exchange
57
12-31
Common stock
4 Oppenheimer, Weizmann Science Park, Rehovot 7670104, Israel
--
CollPlant Biotechnologies Ltd., was incorporated in Israel as a private limited company on November 9, 1981. The company is a regenerative and cosmetic medical company focusing on 3-D bioprinting and medical cosmetology of tissues and organs. The company's products are based on the patented plant genetic engineering technology produced by rhCollagen. The company's products are targeted for indications in a variety of fields, including tissue repair, aesthetics and organ manufacturing. The company's partners include Abbvie, STEMCELL, Tel Aviv University, Sheba Medical Center, ARMI and ReMDO, among others.
